Related references
Note: Only part of the references are listed.Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer
Heyu Song et al.
MOLECULAR CANCER THERAPEUTICS (2020)
SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy
Aleksandr Ianevski et al.
PLOS COMPUTATIONAL BIOLOGY (2020)
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets
Arnaud Amzallag et al.
BMC BIOINFORMATICS (2019)
MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
Ophelia Maertens et al.
CANCER DISCOVERY (2019)
Prediction of ultra-high-order antibiotic combinations based on pairwise interactions
Itay Katzir et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
Geraint Davies et al.
PLOS MEDICINE (2019)
Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls
Anna H. C. Vlot et al.
DRUG DISCOVERY TODAY (2019)
Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines
Farnoosh Abbas-Aghababazadeh et al.
SCIENTIFIC REPORTS (2019)
Emergent Gene Expression Responses to Drug Combinations Predict Higher-Order Drug Interactions
Martin Lukacisin et al.
CELL SYSTEMS (2019)
Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering
Andrea Weiss et al.
CANCERS (2019)
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
Jarno L. Kivioja et al.
LEUKEMIA (2019)
Cisplatin, glutathione and the third wheel: a copper-(1,10-phenanthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin
Sarah Vascellari et al.
RSC ADVANCES (2019)
Prediction of drug combination effects with a minimal set of experiments
Aleksandr Ianevski et al.
NATURE MACHINE INTELLIGENCE (2019)
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
Rinath Jeselsohn et al.
CANCER CELL (2018)
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
Liye He et al.
CANCER RESEARCH (2018)
Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis
Ishag Adam et al.
MALARIA JOURNAL (2018)
Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults
Martina Properzi et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Vasileios Stathias et al.
NATURE COMMUNICATIONS (2018)
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment
Murat Cokol et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Prevalence and patterns of higher-order drug interactions in Escherichia coli
Elif Tekin et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2018)
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
Murat Cokol et al.
SCIENCE ADVANCES (2017)
Synergistic drug combination effectively blocks Ebola virus infection
Wei Sun et al.
ANTIVIRAL RESEARCH (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity
Susan L. Holbeck et al.
CANCER RESEARCH (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Prediction of multidimensional drug dose responses based on measurements of drug pairs
Anat Zimmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Systematic discovery of drug interaction mechanisms
Guillaume Chevereau et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
An automated fitting procedure and software for dose-response curves with multiphasic features
Giovanni Y. Di Veroli et al.
SCIENTIFIC REPORTS (2015)
Computational tools for fitting the Hill equation to dose-response curves
Sudhindra R. Gadagkar et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Uncovering Scaling Laws to Infer Multidrug Response of Resistant Microbes and Cancer Cells
Kevin B. Wood et al.
CELL REPORTS (2014)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
